MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejso.2022.12.019

Медицинская библиотека · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2023

Clinical utility of axillary nodal markers in breast cancer.

Barry Peter A, Harborough Kathryn, Sinnett Victoria, Heeney Anna, St John Edward Robert, Gagliardi Tanja, Bhaludin Basrull N, Downey Kate, Pope Romney, O'Connell Rachel L, Tasoulis Marios K, MacNeill Fiona, Rusby Jennifer E, Gui Gerald, Micha Aikaterini, Chen Samantha, Claudia Krupa Katherine Dorothy

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

De-escalation of axillary surgery for lymph node (LN) positive breast cancer is facilitated by marking involved nodes which, when removed with sentinel nodes constitute risk-adapted targeted axillary dissection (TAD). Whether after chemotherapy or for primary surgery, selected patients with biopsy-proven involvement of nodes may be eligible for axillary conservation. Likewise, impalpable recurrence or stage 4 patients with localised axillary disease may benefit. In these contexts, several devices are used to mark biopsied nodes to facilitate their accurate surgical removal. We report our experience using the paramagnetic MAGSEED (Endomag®, Cambridge, UK).

METHODS

Local approval (BR2021_149) was obtained to interrogate a prospective database of all axillary markers. The primary endpoint was successful removal of the marked LN.

RESULTS

Of 241 markers (in 221 patients) inserted between October 2018 and July 2022, all were retrieved. Of 74 patients who had Magseeds® inserted after completion of NACT (involved nodes initially marked using an UltraCor™Twirl™ marker), the Magseeds® were found outside the node in neighbouring axillary tissue in 18 (24.3%) patients. When Magseeds® were placed at commencement of NACT in 54 patients, in only 1 (1.8%) was the marker found outside the node - a statistically significantly lower rate (Chi2 10.7581 p = 0.001038). For 'primary TAD' patients and those localised for recurrent or stage IV disease, all 93 had the Magseed® found within the biopsied node.

CONCLUSION

This series supports our axillary nodal marking technique as safe and reliable. For TAD following NACT, placement at the start of treatment led to a significantly higher localisation rate.

Для цитирования: Barry Peter A, Harborough Kathryn, Sinnett Victoria, Heeney Anna, St John Edward Robert, Gagliardi Tanja, Bhaludin Basrull N, Downey Kate, Pope Romney, O'Connell Rachel L, Tasoulis Marios K, MacNeill Fiona, Rusby Jennifer E, Gui Gerald, Micha Aikaterini, Chen Samantha, Claudia Krupa Katherine Dorothy. Clinical utility of axillary nodal markers in breast cancer.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2023. DOI: 10.1016/j.ejso.2022.12.019.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.